Hefei Kejing Biotechnology Co., Ltd. was established in 2022 and is a high-tech enterprise dedicated to the deep integration of AI and biotechnology. Since its establishment, the company has rapidly emerged as a leader and technology promoter in the fields of biotechnology and artificial intelligence, thanks to its outstanding research and development capabilities and pioneering technological innovations.

        The company has gathered a group of high-end talents with profound academic expertise and rich practical experience in the fields of biotechnology and artificial intelligence. Through interdisciplinary collaboration, they continue to overcome technical challenges and expand the boundaries of technological applications. We focus on computer-aided high-throughput virtual screening technology, combining advanced methods from bioinformatics, computational biology, and artificial intelligence to develop precise and efficient molecular screening solutions. These technologies have been widely applied in fields such as life science research, medical diagnosis, and new drug development, injecting strong impetus into the industry's development.

        The company's core technologies cover high-throughput virtual screening, integrated applications of bioinformatics and computational biology, as well as intelligent solutions in the field of life sciences. By using AI algorithms to accurately identify potential molecules from massive databases, the company has greatly improved screening efficiency and provided revolutionary support for new drug development and basic biological research. Combining advanced methods from bioinformatics and computational biology, the innovative technology developed by the company not only promotes the intelligent transformation of the biotechnology field, but also opens up new paths for research and application in the field of life sciences. In addition, we provide intelligent life science solutions to provide technical support for customers in the biopharmaceutical, medical diagnosis, and big health industries, helping them accelerate the full process transformation from research to application.